SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-014537
Filing Date
2013-03-12
Accepted
2013-03-12 16:03:07
Documents
14
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v334530_10k.htm 10-K 1115734
2 EXHIBIT 21.1 v334530_ex21-1.htm EX-21.1 2662
3 EXHIBIT 23.1 v334530_ex23-1.htm EX-23.1 6026
4 EXHIBIT 31.1 v334530_ex31-1.htm EX-31.1 10682
5 EXHIBIT 31.2 v334530_ex31-2.htm EX-31.2 10509
6 EXHIBIT 32.1 v334530_ex32-1.htm EX-32.1 3373
7 EXHIBIT 32.2 v334530_ex32-2.htm EX-32.2 3528
8 GRAPHIC image_001.gif GRAPHIC 15968
  Complete submission text file 0001144204-13-014537.txt   7864382

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT kerx-20121231.xml EX-101.INS 1085645
10 XBRL TAXONOMY EXTENSION SCHEMA kerx-20121231.xsd EX-101.SCH 64898
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kerx-20121231_cal.xml EX-101.CAL 51685
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kerx-20121231_def.xml EX-101.DEF 313924
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE kerx-20121231_lab.xml EX-101.LAB 531702
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kerx-20121231_pre.xml EX-101.PRE 404309
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30929 | Film No.: 13684177
SIC: 2834 Pharmaceutical Preparations